Kura Oncology announces annual shareholder meeting via webcast

Kura Oncology, Inc.

Kura Oncology, Inc.

KURA

0.00
  • Kura Oncology schedules annual stockholder meeting in virtual format on June 4, 2026.
  • Director elections planned for three Class III board seats, with terms running to 2029.
  • Vote set on auditor ratification for Ernst & Young as independent accounting firm for fiscal 2026.
  • Advisory votes slated on executive pay package, including preferred frequency of future say-on-pay votes.
  • Stockholders to consider amendments to 2014 equity incentive plan, including 6,500,000-share reserve increase, plus amendment to 2015 employee stock purchase plan, including 2,500,000-share reserve increase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-151335), on April 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.